Glenmark Pharmaceuticals Ltd.
NSE :
GLENMARKBSE :
532296ISIN CODE :
INE935A01035Industry :
Pharmaceuticals & DrugsHouse :
Glenmark
BSE2,194.0531.15 (1.44 %)
PREV CLOSE() 2,162.90
OPEN PRICE () 2,149.05
BID PRICE (QTY) 0.00(0.00)
OFFER PRICE (QTY) 0.00(0.00)
VOLUME 17490
TODAY'S LOW / HIGH()
52 WK LOW / HIGH ()
STOCK SUMMARY
Incorporation Year :
1977
Management Info :
Glenn Saldanha - Chairman Glenn Saldanha - Managing DirectorRegistered Office :
Address :
B/2 Mahalaxmi Chambers,22 Bhulabhai Desai Road, ,
Mumbai,
Maharashtra-400026
Phone :
Website : www.glenmarkpharma.com
Registrar's Details :
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing :
BSE, NSE
09Apr Glenmark Pharmaceuticals ..Glenmark Pharmaceuticals has received final approval from the United Sta..
09Apr Glenmark Pharmaceuticals ..Glenmark Pharmaceuticals has submitted press release stating that Glenma..
23Mar Glenmark Pharmaceuticals ..Glenmark Pharmaceuticals has launched GLIPIQ (semaglutide) in India for ..
21Mar Glenmark Pharmaceuticals..Glenmark Pharmaceuticals has informed that the company research-led, glo..
19Mar Glenmark Pharmaceuticals ..Glenmark Pharmaceuticals has received final approval by the United State..
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
Astrazeneca Pharma I (BSE) 8,718.05 (5.14%) | M.Cap ( in Cr) 21808.37 |
| Onesource Specialty (BSE) 1,543.30 (7.37%) | M.Cap ( in Cr) 17692.8 |
| Ajanta Pharma (BSE) 2,895.85 (3.29%) | M.Cap ( in Cr) 36179.48 |
| Venus Remedies (BSE) 1,039.95 (4.61%) | M.Cap ( in Cr) 1395.31 |
| Acutaas Chemicals (BSE) 2,393.75 (1.27%) | M.Cap ( in Cr) 19597.9 |
| Scheme Name | Hold(%) |
|---|---|
| Mirae Asset Healthca... | 6.94 |
| HDFC Pharma and Heal... | 6.78 |
| Motilal Oswal Nifty ... | 6.1 |
| Tata Nifty MidSmall ... | 6.1 |
| Motilal Oswal Quant ... | 5.07 |
| Bandhan Focused Fund... | 4.69 |
